Studies have shown that PKM2 is overexpressed in several types of tumors, including lung cancer, breast carcinoma, and colorectal carcinoma, and is closely related to cell proliferation, apoptosis resistance, invasion, and migration.19 Here, PKM is linked to breast carcinoma.